Recognized with a Nobel Prize in 2020, CRISPR has opened the floodgates for a new era of gene editing therapies, promising to transform genetic disease treatments. With a well-established early […]

The time has come to remove the pharmaceutical industry’s reliance on archaic off-line testing and embrace the cost and speed-to-market savings of online control and real-time product quality. The PAT […]

Delivering the Next Wave of Gene Therapies to the CNS With systemic toxicity challenges plaguing the AAV field, direct administration for CNS indications creates an ideal target for gene therapy. […]

Cell Therapy Analytical Development Summit US is back for its fourth year, taking place in Boston (December 5-7). Join 180+ colleagues from analytical development, process development, quality control and regulatory affairs, to standardize analytical […]

The 5th Commercializing Clinically Validated Digital Therapeutics Summit, designed with DTx companies, pharma and clinicians, will return this December to address the industry’s major challenges such as improving user experience, […]

The long-awaited 4th Annual Targeted Radiopharmaceuticals Summit Europe is returning in-person in Amsterdam on December 6-8, 2022! As the only devoted meeting for large pharma, biotech and pioneering academics, this meeting unites key stakeholders […]

The field of food allergy therapeutics is continuing to boom as companies flood the news with fresh IND clearances and clinical readouts. The race to market for the next food […]

In the context of a need to regroup and accelerate practice-changing cancer immunotherapies towards approval and to patients in need, the 3rd TIGIT Axis Therapies Summit returns to reunite large pharma, innovative […]

RNA-Targeted Drug Discovery Summit returns for its fifth year this December. Join the summit for deep dive into new and emerging topics such as: Induced Proximity as a new class […]

Returning for a second year the Synthetic Biology-Based Therapies Summit is the leading industry-defining forum made exclusively for leaders in the synthetic and engineered biology space, focusing on the technical challenges that […]

The Advanced Wound Care Summit EU is the first industry-led, EU-focused, forum on commercialising innovative wound care products. How will you comply with the EU MDR? What is the best strategy […]

PURIFY Conclaves are pioneers of dedicated conferences in India that will help stretch possibilities, be it discovery, development or scaleups! The pharmaceutical industry continues to dwell deeper into the growing […]

SAE Media Group’s 15th Annual Conference Pre-Filled Syringes and Injectable Drug Devices Europe January 10 - 12 2023 | London, UK http://www.pre-filled-syringes.com/pharmajournalist ------------------------------------------------------------------------- The pre-filled syringes industry is growing at […]

11th Annual Pharmaceutical Microbiology Conference  16 - 17 January 2023 London, UK http://www.pharma-microbiology.com/PJwl  Sponsored by: Microgenetics  Co-chairs Di Morris, Clinical Auditor, AstraZeneca and Nigel Cryer, Deputy Director Global Audit, Sanofi  Harnessing […]

The inaugural Spatial Biology for Immuno-Oncology Summit runs at a crucial moment in time. Spurred on by technological advancement and successful case studies, spatial technologies are set to become increasingly mainstream […]

SAE Media Group’s 2nd Annual Conference Transdermal and Microneedle Drug Delivery January 23 - 24, 2023 | London, UK www.transdermal-microneedle-delivery.co.uk/pharmajournalistel ------------------------------------------------------------------------- SAE Media Group is proud to present the 2nd […]

The 2nd Annual mRNA-Based Therapeutics Summit Europe is the only end-to-end mRNA-dedicated meeting in Europe and the largest gathering for mRNA professionals outside of the United States. Built with biopharmaceutical […]

The 6th DDR Inhibitors Summit is taking place in-person for the first time in 3 years in Boston, MA this January 24 – 26, 2023. The DNA damage response inhibitor space only […]

The 2nd HFpEF & HCM Drug Discovery & Development Summit is the definitive industry forum dedicated to propelling drug discovery and development across emerging therapeutics including cell and gene therapies […]

Exploit Understanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology. In the past year alone, the field has […]

Over the last few decades, immunotherapy has developed at a rapid rate in the treatment of cancer where neoantigens are the latest breakthrough in tumour immunotherapy. Today, it is still […]

SAE Media Group invites you to join the 14th Annual RNA Therapeutics Conference, taking place on 8 and 9 February 2023, in London, UK. Building on the success of previous […]

Introducing the only industry forum exclusively bringing together key decision-makers, within health insurers and providers, who are responsible for payment and revenue integrity, value-based payment, and networking relations. At a […]

6th Annual 3D Cell Culture Conference 8-9 February 2022 London, UK http://www.3D-cellculture.com/PJwl Sponsored: CelVivo, Promega and Systemic Bio Conference Co-chairs: Phillip Hewitt, Global Head of Early Investigative Toxicology, Merck Rhiannon David, […]

The 5th Annual CRISPR AgBio Congress will unite research heads, molecular biologists, regulatory experts, and product developers from large Ag companies, innovative AgBiotechs, academic groups and regulatory bodies to translate […]

Retinal Vascular Disease Drug Development Summit is an event dedicated to creating a community space dedicated to overcoming the current challenges in drug development for retinal vascular diseases. The management […]

 Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to make CAR […]

The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy […]

Welcome to the 11th Alzheimer’s & Parkinson’s Drug Development Summit With a surge in preclinical investment, fresh news of clinical pipeline progressions, and a new era of therapies pending FDA approvals […]

Since Kinase inhibitors have proven to be efficacious and approvable targets, fuelling recent investment into this exciting space as their therapeutic targeting is explored beyond oncology. However, increasing resistance to […]